VHL and cancer: Recently, Zhang et al. revealed a pan-cancer proteogenomic atlas for PI3K/AKT/mTOR changes across over 10,000 human cancers, supporting the notion that VHL mutations are associated with highly active AKT/mTOR signaling [39].